Skip to main content
Premium Trial:

Request an Annual Quote

BD Shares Surge 7.2 Percent on Strong Fiscal Q1 Earnings

NEW YORK, Jan. 26 (GenomeWeb News) - Becton Dickinson sharers were up 7.24 percent, or $4.28,  at $63.39 today after the company reported stronger-than-expected fiscal first-quarter earnings.

 

As GenomeWeb News reported this morning, total receipts for the Biosciences unit during the three months ended Dec. 31, 2005, increased to $199.5 million from $180.8 million year over year.

 

Around $85 million of that was from sales in the United States, representing a 12.7-percent increase in sales to that country. The remainder, or approximately $114 million, was in international sales, which represented an 8.7-percent increase in sales.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.